These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Gardner MJ, Bishop R, Shah T, de Villiers EP, Carlton JM, Hall N, Ren Q, Paulsen IT, Pain A, Berriman M, Wilson RJ, Sato S, Ralph SA, Mann DJ, Xiong Z, Shallom SJ, Weidman J, Jiang L, Lynn J, Weaver B, Shoaibi A, Domingo AR, Wasawo D, Crabtree J, Wortman JR, Haas B, Angiuoli SV, Creasy TH, Lu C, Suh B, Silva JC, Utterback TR, Feldblyum TV, Pertea M, Allen J, Nierman WC, Taracha EL, Salzberg SL, White OR, Fitzhugh HA, Morzaria S, Venter JC, Fraser CM, Nene V. Science; 2005 Jul 01; 309(5731):134-7. PubMed ID: 15994558 [Abstract] [Full Text] [Related]
3. Screening and identification of Theileria annulata subtelomere-encoded variable secreted protein-950454 (SVSP454) interacting proteins from bovine B cells. Li Z, Liu J, Ma Q, Liu A, Li Y, Guan G, Luo J, Yin H. Parasit Vectors; 2021 Jun 11; 14(1):319. PubMed ID: 34116718 [Abstract] [Full Text] [Related]
5. Theileria annulata subtelomere-encoded variable secreted protein-TA05560 interacts with bovine RNA binding motif protein 39 (RBM39). Ma Q, Han Y, Fu Y, Teng G, Wang X, Liu J, Li Z. Acta Trop; 2024 Apr 11; 252():107133. PubMed ID: 38280638 [Abstract] [Full Text] [Related]
7. Post-translational signal peptide cleavage controls differential epitope recognition in the QP-rich domain of recombinant Theileria parva PIM. Casanova CL, Xue G, Taracha EL, Dobbelaere DA. Mol Biochem Parasitol; 2006 Oct 11; 149(2):144-54. PubMed ID: 16806529 [Abstract] [Full Text] [Related]
10. Evidence for the induction of casein kinase II in bovine lymphocytes transformed by the intracellular protozoan parasite Theileria parva. ole-MoiYoi OK, Brown WC, Iams KP, Nayar A, Tsukamoto T, Macklin MD. EMBO J; 1993 Apr 11; 12(4):1621-31. PubMed ID: 8467809 [Abstract] [Full Text] [Related]
12. Transcriptomics reveal potential vaccine antigens and a drastic increase of upregulated genes during Theileria parva development from arthropod to bovine infective stages. Tonui T, Corredor-Moreno P, Kanduma E, Njuguna J, Njahira MN, Nyanjom SG, Silva JC, Djikeng A, Pelle R. PLoS One; 2018 Apr 11; 13(10):e0204047. PubMed ID: 30303978 [Abstract] [Full Text] [Related]
14. Theileria parva: taking control of host cell proliferation and survival mechanisms. Dobbelaere DA, Fernandez PC, Heussler VT. Cell Microbiol; 2000 Apr 11; 2(2):91-9. PubMed ID: 11207566 [Abstract] [Full Text] [Related]
15. Role of the polymorphic immunodominant molecule in entry of Theileria parva sporozoites into bovine lymphocytes. Toye P, Musoke A, Naessens J. Infect Immun; 2014 May 11; 82(5):1786-92. PubMed ID: 24549329 [Abstract] [Full Text] [Related]
16. Characterization of the gene encoding the polymorphic immunodominant molecule, a neutralizing antigen of Theileria parva. Toye PG, Metzelaar MJ, Wijngaard PL, Nene V, Iams K, Roose J, Nyanjui JK, Gobright E, Musoke AJ, Clevers HC. J Immunol; 1995 Aug 01; 155(3):1370-81. PubMed ID: 7636202 [Abstract] [Full Text] [Related]
18. Differential in vitro and in vivo expression of MHC class II antigens in bovine lymphocytes infected by Theileria parva. DeMartini JC, MacHugh ND, Naessens J, Teale AJ. Vet Immunol Immunopathol; 1993 Jan 01; 35(3-4):253-73. PubMed ID: 8430496 [Abstract] [Full Text] [Related]
20. MDM2 regulates a novel form of incomplete neoplastic transformation of Theileria parva infected lymphocytes. Hayashida K, Kajino K, Hattori M, Wallace M, Morrison I, Greene MI, Sugimoto C. Exp Mol Pathol; 2013 Feb 01; 94(1):228-38. PubMed ID: 22981919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]